Three‐dimensional structures of carbohydrate determinants of Lewis system antigens: Implications for effective antibody targeting of cancer-Reference-Cited by-同舟云学术

Three‐dimensional structures of carbohydrate determinants of Lewis system antigens: Implications for effective antibody targeting of cancer

Published:2005-10-21 Issue:6 Volume:83 Page:709-717
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Yuriev Elizabeth¹,Farrugia William²,Scott Andrew M³,Ramsland Paul A²

Affiliation:

1. Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University Victoria Australia

2. Structural Immunology Laboratory, Austin Research Institute Victoria Australia

3. Tumour Targeting Program, Ludwig Institute for Cancer Research Melbourne Victoria Australia

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1440-1711.2005.01374.x

Reference55 articles.

1. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor‐derived cell lines.;Sakamoto J;Cancer Res.,1986

2. Expression of Blood Group-Related Antigens, ABH, Lewisa, Lewisb, Lewisx, Lewisy, CA19-9, and CSLEX1 in Early Cancer, Intestinal Metaplasia, and Uninvolved Mucosa of the Stomach

3. Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer

4. Magic bullets hit the target

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated carbohydrate antigens of MUC1 – Implication in cancer development;Biomedicine & Pharmacotherapy;2024-05

2. Protein glycosylation in cancer;Translational Glycobiology in Human Health and Disease;2024

3. Conformational Studies of Oligosaccharides;Chemistry – A European Journal;2020-07-09

4. Finding new lanes: Chimeric antigen receptor (CAR) T‐cells for myeloid leukemia;CANCER REPORTS;2020-04

5. Chimeric Antigen Receptor-Engineered T Cell Therapy in Acute Myeloid Leukaemia;European Medical Journal;2018-09-04